Bioinformatic exploration of structural and functional features of genes associated with rare diseases.
Keywords:
Rare diseases, Human genome, Bioinformatics, GenesAbstract
Objective: Rare diseases have been related to rare variants with a high penetrance for many genes, however, these genes that cause rare diseases are not necessarily rare genes, because they are related to several essential pathways for cells, and in many cases are common for rare and common diseases. Consequently, it is possible to propose that the genes causing rare diseases could be related to fundamental processes or critical regions in the human genome. In this study, we explore the genes causing rare diseases based on a description of their structure and function for the identification of critical functional processes and a gene regulatory context for their association with specific diseases that can be explored. Materials and methods: The genes causing rare diseases, extracted from the ORPHANET and OMIM database, were explored to identify if there is any similarity within their structural and functional characteristics. In addition, a systematic review of the literature is carried out in order to capture the most relevant diseases found in the bioinformatic analysis. Results: Here we report that the genes that cause rare diseases are related to fundamental cellular processes, whose genes are found in genomic regions with a high density of repeats. Our data show metabolism, disease and cellular processes, as the most frequent categories associated with genes causing rare diseases, which include critical pathways for cell viability such as glycosaminoglycan degradation, primary immunodeficiency or cell junctions. Conclusions: Our results establish a general description of the basic structural characteristics of genes related to rare diseases, in addition to establishing key processes that describe rare diseases in cellular contexts common to other diseases, these processes being important for future explorations.
Downloads
References
Pareja ML. Situación actual de las enfermedades huerfanas en Colombia 2017. Revista CES Derecho. 2017; 2(8):231-241
Ospina M, Prieto F, Walteros D, Quijada H. Vigilancia y análisis del riesgo en salud pública y protocolo de vigilancia en salud pública huérfanas-raras. Ministerio de Salud y Protección Social; 2019.
Orphanet. Acerca de Oprhanet: Nuestra misión; 2020.
Rimel JK, Taatjes DJ. The essential and multifunctional TFIIH complex. Protein Sci. 2018;27(6):1018-1037. DOI: 10.1002/pro.3424
Martínez-Ospina AP, Porras-Ramírez A, Rico-Mendoza A. Epidemiología de cáncer de ovario colombia 2009-2016. Rev Chil Obstet Ginecol. 2019; 84(6):480-489.
Enfermedad de almacenamiento de glucógeno por deficiencia de glucosa-6-fosfatasa. Enciclopedia de Orphanet; 2020.
Pérez-Mendoza M, De Ita-Pérez D, Díaz-Muñoz M. Gluconeogénesis: Una visión contemporánea de una vía metabólica antigua. REB. 2012; 31(1):10-20.
Guo T, Chen T, Gu C, Li B, Xu C. Genetic and molecular analyses reveal G6PC as a key element connecting glucose metabolism and cell cycle control in ovarian cancer. Tumour Biol. 2015; 36(10):7649-58. DOI: 10.1007/s13277-015-3463-6
Higuera M. Regulación de las vías MAPK y Akt-Fox01 en el mecanismo molecular de acción del Minerval contra el cáncer de pulmón y glioma. Universitat de les Illes Belears; 2011.
Xu WH, Xu Y, Tian X, Anwaier A, Liu WR, Wang J et al. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma. J Cell Mol Med. 2020; 24(16):9012–27. DOI: 10.1111/jcmm.15536.
Riggins G. Riggins C. Genetic Origins of Brain Tumors. Youmans and Winn Neurological Surgery. 2017; 114:806-813
Knobbe, A. Kieslich, T. Reifenberger, G. Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas. Neuropathology and Applied Neurobiology (2005), 31, 486–490. doi: 10.1111/j.1365-2990.2005.00660.x
Khoury, Katia. Tan, Antoinette, et al. Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast Cancer. Frontiers in Oncology (2020). 10, 1475. https://doi.org/10.3389/fonc.2020.01475
Urbschat A, Paulus P, von Quernheim QF, Brück P, Badenhoop K, Zeuzem S, Ramos-Lopez E. Vitamin D hydroxylases CYP2R1, CYP27B1 and CYP24A1 in renal cell carcinoma. Eur J Clin Invest. 2013; 43(12):1282-90. DOI: 10.1111/eci.12176
Raquitismo hipocalcémico dependiente de vitamina D. Enciclopedia de Orphanet; 2020.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Salutem Scientia Spiritus

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
La Revista Salutem Scientia Spiritus usa la licencia Creative Commons de Atribución – No comercial – Sin derivar: Los textos de la revista son posibles de ser descargados en versión PDF siempre que sea reconocida la autoría y el texto no tenga modificaciones de ningún tipo.